{{Rsnum
|rsid=1786929
|Gene=CTNNA3
|Chromosome=10
|position=67679048
|Orientation=minus
|GMAF=0.2847
|Assembly=GRCh37.p10
|GenomeBuild=37.5
|dbSNPBuild=138
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 8.8 | 41.6 | 49.6
| HCB | 12.5 | 51.5 | 36.0
| JPT | 16.1 | 50.9 | 33.0
| YRI | 0.7 | 8.2 | 91.2
| ASW | 0.0 | 22.8 | 77.2
| CHB | 12.5 | 51.5 | 36.0
| CHD | 11.9 | 46.8 | 41.3
| GIH | 5.9 | 45.5 | 48.5
| LWK | 0.0 | 15.6 | 84.4
| MEX | 8.6 | 37.9 | 53.4
| MKK | 3.2 | 28.8 | 67.9
| TSI | 5.9 | 43.6 | 50.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=24407380
|Title=Polymorphisms in recent GWA identified asthma genes CA10, SGK493, and CTNNA3 are associated with disease severity and treatment response in childhood asthma
}}

{{PMID Auto
|PMID=19187332
|Title=Alpha-T-catenin (CTNNA3) gene was identified as a risk variant for toluene diisocyanate-induced asthma by genome-wide association analysis.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}